© 2021 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Fetal Fibronectin: The Benefits of a High Negative Predictive Value in Management of Preterm Labor
Dr. McCue is Chief, Ob/Gyn and Midwifery, Beth Israel Deaconess Hospital-Plymouth, Plymouth, Massachusetts.
The clinical diagnosis of preterm labor (PTL) has up to a 50% false-positive rate, often leading to unnecessary hospitalizations and interventions. What objective tools can clinicians use to accurately diagnose true PTL - and reduce the drain on resources and overexposure to treatments?
" >
The clinical diagnosis of preterm labor (PTL) has up to a 50% false-positive rate, often leading to unnecessary hospitalizations and interventions. What objective tools can clinicians use to accurately diagnose true PTL - and reduce the drain on resources and overexposure to treatments?
This supplement discusses considerations and strategies for assessing PTL that include:
- The role of diagnostic testing for fetal fibronectin (fFN) in the work up of women with symptoms of PTL
- The importance of combining fFN values with cervical length measurement
- Evidence-based protocols for the evaluation of PTL
- A summary of evidence verifying the cost savings associated with the evaluation protocol
Read the supplement now to learn more about the management of PTL.
Download Supplement